Ocinaplon
奥西普隆
Report date: 2023/04/21 16:05:22
NME
Base Information
Drug NameOcinaplon
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPfizer IncEuthymics Bioscience Inc
Active IndicationsN/A
Inactive Indications